Skip to main content

Table 1 The expression level of TET1 in different malignant diseases and subtypes

From: Advances in the DNA methylation hydroxylase TET1

Malignant Diseases

Subtypes

Expression Level of TET1

Leukemia

AML

Low

T-ALL

High

Breast Cancer

HER2

Unchanged

HRBC

Low

Triple Negative

High

Lung Cancer

Adenocarcinoma

High

Squamous Cell Carcinoma

High

Hepatocellular Carcinoma

–

Low

Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

Low

Colon Cancer

–

Low

Pancreatic Cancer

–

Low

Prostate Cancer

–

Low

Cervical Cancer

–

High